Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1T | 2.0T | 2.0T | 1.8T |
Cost of revenue | 1.8T | 1.7T | 1.7T | 1.5T |
Gross profit | 322.5B | 336.2B | 367.7B | 332.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 82.6B | 107.0B | 114.1B | 69.6B |
Other operating expenses | 2.4B | 10.2B | 10.2B | 12.3B |
Operating income | 95.0B | 72.4B | 117.8B | 115.8B |
Non operating interest income | ||||
Income | 1.2B | 1.6B | 778M | 741M |
Expense | 26.2B | 24.0B | 26.1B | 21.8B |
Other income expense | — | — | — | — |
Pretax income | 62.8B | 33.2B | 73.4B | 91.4B |
Tax provision | 13.4B | 9.1B | 21.6B | 38.3B |
Net income | 49.4B | 24.2B | 51.8B | 53.1B |
Basic EPS | 26 | — | — | — |
Diluted EPS | 26 | — | — | — |
Basic average shares | 1.5B | — | — | — |
Diluted average shares | 1.5B | — | — | — |
EBITDA | 75.1B | 86.5B | 110.6B | 127.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -10.4B | 13.5B | -5.6B | -4.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |